8-K12B: ProKidney Corp. Completes Delaware Domestication and Comprehensive Corporate Restructuring

ProKidney Corp. has successfully completed its planned domestication from the Cayman Islands to Delaware, alongside a significant corporate restructuring and the amendment of key governance and financial agreements, effective July 1, 2025.

Summary

• ProKidney Corp. (formerly a Cayman Islands exempted company) has completed its domestication to the State of Delaware, effective July 1, 2025, changing its jurisdiction of incorporation.
• The restructuring involved ProKidney LP (Ireland) contributing substantially all assets to a newly formed Delaware limited liability company, ProKidney Holdings, LLC, which now owns all business subsidiaries, including ProKidney IPCo, LLC (also domesticated to Delaware).
• Existing Class A and Class B ordinary shares of the former Cayman entity were automatically converted into Class A and Class B common stock of the new Delaware corporation on a one-to-one basis.
• Restricted Stock Rights (Class B Series 1, 2, 3, and PMEL RSRs) of the Cayman entity were converted into corresponding restricted stock rights for Class B common stock of the Delaware entity, retaining their original vesting conditions.
• The company's Class A common stock continues to be listed for trading on the Nasdaq Stock Market under the symbol PROK, and its CUSIP number changed to 74291D 104 effective July 2, 2025.
• Key material agreements, including the Tax Receivable Agreement, Lock-Up Agreement, and Exchange Agreement, were amended and restated to reflect the new corporate structure and ensure continuity of terms.
• A Second Amended and Restated Limited Liability Company Agreement for ProKidney Holdings was adopted, outlining the governance of ProKidney Holdings, including the management by a Holdings Board (initially three persons, expandable to ten) appointed by ProKidney Corp. (Delaware).
• The new corporate governance documents, including the Certificate of Incorporation and Bylaws, now govern the rights of stockholders under Delaware law.

Sentiment

Score: 5

Explanation: The document is purely procedural, detailing a planned corporate restructuring and domestication. It contains no financial performance data or operational updates that would influence sentiment positively or negatively.

Positives

• The domestication to Delaware provides the company with the benefits of Delaware's well-established corporate law, which is generally favored by investors and corporations for its predictability and flexibility.
• The restructuring simplifies the corporate ownership structure, consolidating business operations under ProKidney Holdings, LLC, which may improve operational efficiency and transparency.
• The amended agreements ensure continuity of existing rights and obligations for security holders and other parties, minimizing disruption from the structural changes.
• The new corporate governance framework, including the staggered board and specific rules for director removal, aims to provide stability and clear lines of authority.

Negatives

• The complex multi-step restructuring process, involving multiple entity changes and asset transfers across different jurisdictions, could introduce administrative complexities and potential unforeseen issues.
• The detailed tax implications of the restructuring and the Tax Receivable Agreement are complex and depend on future tax savings, which may not materialize as expected.
• The explicit waiver of certain fiduciary duties for non-officer/director members and affiliates in the Holdings LLCA, while permitted by Delaware law, could be perceived as reducing protections for certain stakeholders, though it aims to clarify corporate opportunity doctrine.

Risks

• Potential for material inaccuracies in tax schedules or calculations under the Tax Receivable Agreement, requiring reconciliation procedures or expert determination.
• Risk of insufficient taxable income for Corporate Taxpayer to fully utilize tax attributes, potentially limiting Realized Tax Benefits and subsequent Tax Benefit Payments.
• Failure to make timely Tax Benefit Payments due to insufficient funds or obligations imposed by Senior Obligations, though interest accrues on late payments.
• Risk that the company's operations or structure could cause ProKidney Holdings to be treated as a publicly traded partnership under Section 7704 of the Code, which could have adverse tax consequences, despite efforts to mitigate this risk.
• Restrictions on transfers of Units and Class B Common Shares, including lock-up periods and requirements for Board consent, could limit liquidity for certain holders.
• Potential for disputes regarding the interpretation or application of the complex tax and corporate governance provisions within the amended agreements.

Future Outlook

The document primarily details a completed corporate restructuring and does not provide specific forward-looking financial guidance or operational outlook. It establishes the legal and structural framework for future operations under Delaware law.

Management Comments

• Todd C. Girolamo, Chief Legal Officer, signed the report and is noted as the Sole Incorporator of ProKidney Corp. (Delaware).
• Bruce Culleton, M.D., is listed as Chief Executive Officer and a contact for the company.
• Pablo Legorreta is listed as the Chairperson of the Holdings Board.

Industry Context

This corporate domestication and restructuring aligns with a common trend among companies initially incorporated in offshore jurisdictions (like the Cayman Islands) to reincorporate in Delaware. This move is often undertaken to benefit from Delaware's well-developed and predictable corporate legal framework, which is widely understood and favored by U.S. investors and capital markets. It can simplify compliance with U.S. securities laws and potentially enhance investor confidence by aligning with standard U.S. corporate governance practices.

Comparison to Industry Standards

• The domestication to Delaware is a standard practice for companies seeking to align with U.S. corporate governance norms, often seen as more robust and transparent than those in offshore jurisdictions. This move is common among companies that have gone public via SPAC mergers, as ProKidney did.
• The adoption of a staggered board (Class I, II, III) is a common governance structure, though it can be viewed as a takeover defense mechanism, potentially limiting shareholder influence compared to annually elected boards.
• The indemnification provisions, including the company being the 'indemnitor of first resort' and the explicit waiver of certain fiduciary duties for non-officer/director members, are specific to Delaware law and common in complex corporate structures involving LLCs and public corporations (Up-C structures). These provisions aim to protect individuals serving the company while clarifying the scope of their duties, which is a standard practice in such arrangements.
• The Tax Receivable Agreement (TRA) is a typical feature of 'Up-C' structures, designed to monetize tax attributes for pre-IPO owners, and its terms (e.g., 85% sharing of tax savings, interest rates) are generally within industry norms for such agreements.

Management Changes

Corporate Governance

Related Party Transactions

• The Amended and Restated Tax Receivable Agreement involves payments from ProKidney Delaware to holders of common units of ProKidney Holdings (TRA Parties), who are former limited partners of PKLP and now members of ProKidney Holdings, based on tax savings from basis adjustments.
• The Amended and Restated Lock-Up Agreement applies to certain 'ProKidney Holders' (equityholders of ProKidney Holdings, LLC) and 'Sponsor Key Holders', restricting their ability to transfer shares.
• The Amended and Restated Exchange Agreement allows 'Holdings Unitholders' (members of ProKidney Holdings) to exchange their common units and Class B common shares for Class A common shares or cash.
• The Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings governs the relationship and rights among ProKidney Corp. (as a member), other members, and the Holdings Board, including provisions for tax distributions and mandatory exchanges that affect members differently based on their holdings.

Stakeholder Impact

• **Shareholders (Class A Common Stock)**: Their shares are now governed by Delaware law, which is generally seen as more robust and predictable. The continuity of Nasdaq listing and CUSIP change are administrative. The lock-up agreements and exchange mechanisms for other unit holders could affect future float and trading dynamics.
• **Holders of Common Units/Class B Common Shares (TRA Parties/Holdings Unitholders)**: Their rights to exchange units for Class A common stock, receive tax benefit payments, and be subject to lock-up restrictions are explicitly defined and continued under the new Delaware framework. The tax distribution mechanism aims to fund their tax obligations.
• **Employees**: The amendments to the Employee Stock Purchase Plan and 2022 Incentive Equity Plan ensure continuity of their equity compensation benefits under the new corporate structure.
• **Management/Directors**: The new Certificate of Incorporation and Bylaws define their roles, responsibilities, and protections (indemnification, limited liability), which are generally favorable under Delaware law. The staggered board structure provides stability for current directors.
• **Regulatory Authorities**: The domestication and detailed filings ensure compliance with U.S. securities regulations, providing transparency regarding the company's new legal and corporate structure.

Next Steps

• The company will continue to operate under its new Delaware corporate structure.
• The amended agreements (TRA, Lock-Up, Exchange, Holdings LLCA, Indemnity) will govern future interactions and transactions with relevant parties.
• The company will continue to file tax returns and provide tax information to TRA parties as per the amended Tax Receivable Agreement.
• Future exchanges of common units for Class A common stock will occur under the terms of the Amended and Restated Exchange Agreement.

Key Dates

Recommendation

Keywords

Corporate Domestication, Delaware Corporation, Corporate Restructuring, SEC Filing, 8-K, ProKidney Corp., Tax Receivable Agreement, Lock-Up Agreement, Exchange Agreement, Limited Liability Company Agreement, Corporate Governance, Shareholder Rights, Tax Implications, Biopharmaceutical